Phoremost and Thinkcyte partner on phenotypic drug discovery
The partners have come together to apply artificial intelligence to phenotypic drug screening, with the aim of developing therapies in different therapeutics areas.
The partners have come together to apply artificial intelligence to phenotypic drug screening, with the aim of developing therapies in different therapeutics areas.
As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.
Clinical operations digital maturity, capability prioritization, and best practice adoption vary widely at the world’s largest pharma firms, according to a survey of senior leaders at the companies.